nodes	percent_of_prediction	percent_of_DWPC	metapath
Mirtazapine—CYP2C8—Ifosfamide—testicular cancer	0.0675	0.228	CbGbCtD
Mirtazapine—CYP2C9—Ifosfamide—testicular cancer	0.0471	0.159	CbGbCtD
Mirtazapine—CYP2C8—Etoposide—testicular cancer	0.0323	0.109	CbGbCtD
Mirtazapine—HTR7—vas deferens—testicular cancer	0.032	0.36	CbGeAlD
Mirtazapine—CYP3A4—Ifosfamide—testicular cancer	0.0274	0.0927	CbGbCtD
Mirtazapine—CYP1A2—Etoposide—testicular cancer	0.025	0.0845	CbGbCtD
Mirtazapine—CYP2C9—Cisplatin—testicular cancer	0.0229	0.0775	CbGbCtD
Mirtazapine—CYP2D6—Vinblastine—testicular cancer	0.0228	0.0773	CbGbCtD
Mirtazapine—CYP3A4—Vinblastine—testicular cancer	0.0145	0.0491	CbGbCtD
Mirtazapine—CYP2D6—Doxorubicin—testicular cancer	0.014	0.0475	CbGbCtD
Mirtazapine—HTR7—vein—testicular cancer	0.0136	0.153	CbGeAlD
Mirtazapine—CYP3A4—Etoposide—testicular cancer	0.0131	0.0443	CbGbCtD
Mirtazapine—CYP3A4—Doxorubicin—testicular cancer	0.00893	0.0302	CbGbCtD
Mirtazapine—HTR2A—vein—testicular cancer	0.00849	0.0953	CbGeAlD
Mirtazapine—DRD4—testis—testicular cancer	0.00401	0.045	CbGeAlD
Mirtazapine—ADRA2C—seminal vesicle—testicular cancer	0.00222	0.025	CbGeAlD
Mirtazapine—SLC6A2—gonad—testicular cancer	0.00181	0.0204	CbGeAlD
Mirtazapine—ADRA2A—seminal vesicle—testicular cancer	0.00177	0.0199	CbGeAlD
Mirtazapine—HTR7—gonad—testicular cancer	0.00175	0.0196	CbGeAlD
Mirtazapine—SLC6A3—testis—testicular cancer	0.00162	0.0182	CbGeAlD
Mirtazapine—HTR2A—embryo—testicular cancer	0.00161	0.018	CbGeAlD
Mirtazapine—SLC6A2—testis—testicular cancer	0.00131	0.0147	CbGeAlD
Mirtazapine—ADRA2C—female gonad—testicular cancer	0.00131	0.0147	CbGeAlD
Mirtazapine—ADRA2A—gonad—testicular cancer	0.00128	0.0144	CbGeAlD
Mirtazapine—HTR7—testis—testicular cancer	0.00126	0.0141	CbGeAlD
Mirtazapine—DRD2—testis—testicular cancer	0.00119	0.0134	CbGeAlD
Mirtazapine—ADRA2C—testis—testicular cancer	0.00116	0.013	CbGeAlD
Mirtazapine—HTR2A—gonad—testicular cancer	0.00109	0.0122	CbGeAlD
Mirtazapine—CYP2C8—testis—testicular cancer	0.00107	0.0121	CbGeAlD
Mirtazapine—HTR2B—lymph node—testicular cancer	0.00107	0.012	CbGeAlD
Mirtazapine—HRH1—female gonad—testicular cancer	0.00106	0.0119	CbGeAlD
Mirtazapine—ADRA2A—female gonad—testicular cancer	0.00104	0.0117	CbGeAlD
Mirtazapine—SLC6A2—lymph node—testicular cancer	0.000948	0.0106	CbGeAlD
Mirtazapine—HRH1—testis—testicular cancer	0.000941	0.0106	CbGeAlD
Mirtazapine—ADRA2A—testis—testicular cancer	0.000924	0.0104	CbGeAlD
Mirtazapine—ADRA2C—lymph node—testicular cancer	0.000839	0.00942	CbGeAlD
Mirtazapine—CYP2D6—female gonad—testicular cancer	0.000807	0.00906	CbGeAlD
Mirtazapine—HTR2A—testis—testicular cancer	0.000786	0.00882	CbGeAlD
Mirtazapine—CYP2D6—testis—testicular cancer	0.000716	0.00804	CbGeAlD
Mirtazapine—HRH1—lymph node—testicular cancer	0.000682	0.00766	CbGeAlD
Mirtazapine—ADRA2A—lymph node—testicular cancer	0.00067	0.00752	CbGeAlD
Mirtazapine—Drowsiness—Doxorubicin—testicular cancer	0.000313	0.000514	CcSEcCtD
Mirtazapine—Stevens-Johnson syndrome—Doxorubicin—testicular cancer	0.00031	0.000509	CcSEcCtD
Mirtazapine—Vomiting—Ifosfamide—testicular cancer	0.00031	0.000508	CcSEcCtD
Mirtazapine—Hypersensitivity—Cisplatin—testicular cancer	0.000309	0.000508	CcSEcCtD
Mirtazapine—Bradycardia—Epirubicin—testicular cancer	0.000309	0.000507	CcSEcCtD
Mirtazapine—Rash—Ifosfamide—testicular cancer	0.000307	0.000504	CcSEcCtD
Mirtazapine—Dermatitis—Ifosfamide—testicular cancer	0.000307	0.000504	CcSEcCtD
Mirtazapine—Erythema multiforme—Methotrexate—testicular cancer	0.000307	0.000503	CcSEcCtD
Mirtazapine—Urticaria—Etoposide—testicular cancer	0.000306	0.000502	CcSEcCtD
Mirtazapine—Stomatitis—Doxorubicin—testicular cancer	0.000305	0.000501	CcSEcCtD
Mirtazapine—Jaundice—Doxorubicin—testicular cancer	0.000305	0.000501	CcSEcCtD
Mirtazapine—Rhinitis—Epirubicin—testicular cancer	0.000304	0.0005	CcSEcCtD
Mirtazapine—Abdominal pain—Etoposide—testicular cancer	0.000304	0.000499	CcSEcCtD
Mirtazapine—Body temperature increased—Etoposide—testicular cancer	0.000304	0.000499	CcSEcCtD
Mirtazapine—Conjunctivitis—Doxorubicin—testicular cancer	0.000304	0.000499	CcSEcCtD
Mirtazapine—Urinary tract infection—Doxorubicin—testicular cancer	0.000304	0.000499	CcSEcCtD
Mirtazapine—Hepatitis—Epirubicin—testicular cancer	0.000304	0.000498	CcSEcCtD
Mirtazapine—Eye disorder—Methotrexate—testicular cancer	0.000303	0.000498	CcSEcCtD
Mirtazapine—Tinnitus—Methotrexate—testicular cancer	0.000302	0.000496	CcSEcCtD
Mirtazapine—Hypoaesthesia—Epirubicin—testicular cancer	0.000302	0.000496	CcSEcCtD
Mirtazapine—Asthenia—Cisplatin—testicular cancer	0.000301	0.000495	CcSEcCtD
Mirtazapine—Pharyngitis—Epirubicin—testicular cancer	0.000301	0.000495	CcSEcCtD
Mirtazapine—Cardiac disorder—Methotrexate—testicular cancer	0.000301	0.000494	CcSEcCtD
Mirtazapine—Sweating—Doxorubicin—testicular cancer	0.0003	0.000492	CcSEcCtD
Mirtazapine—Urinary tract disorder—Epirubicin—testicular cancer	0.0003	0.000492	CcSEcCtD
Mirtazapine—Oedema peripheral—Epirubicin—testicular cancer	0.000299	0.000491	CcSEcCtD
Mirtazapine—Haematuria—Doxorubicin—testicular cancer	0.000298	0.00049	CcSEcCtD
Mirtazapine—Urethral disorder—Epirubicin—testicular cancer	0.000298	0.000488	CcSEcCtD
Mirtazapine—Hepatobiliary disease—Doxorubicin—testicular cancer	0.000296	0.000486	CcSEcCtD
Mirtazapine—Epistaxis—Doxorubicin—testicular cancer	0.000295	0.000484	CcSEcCtD
Mirtazapine—Angiopathy—Methotrexate—testicular cancer	0.000294	0.000483	CcSEcCtD
Mirtazapine—Sinusitis—Doxorubicin—testicular cancer	0.000294	0.000482	CcSEcCtD
Mirtazapine—Agranulocytosis—Doxorubicin—testicular cancer	0.000292	0.000479	CcSEcCtD
Mirtazapine—Chills—Methotrexate—testicular cancer	0.000291	0.000478	CcSEcCtD
Mirtazapine—Nausea—Ifosfamide—testicular cancer	0.000289	0.000475	CcSEcCtD
Mirtazapine—Diarrhoea—Cisplatin—testicular cancer	0.000287	0.000472	CcSEcCtD
Mirtazapine—Erythema multiforme—Epirubicin—testicular cancer	0.000287	0.000471	CcSEcCtD
Mirtazapine—Alopecia—Methotrexate—testicular cancer	0.000287	0.00047	CcSEcCtD
Mirtazapine—Bradycardia—Doxorubicin—testicular cancer	0.000286	0.000469	CcSEcCtD
Mirtazapine—Mental disorder—Methotrexate—testicular cancer	0.000284	0.000466	CcSEcCtD
Mirtazapine—Eye disorder—Epirubicin—testicular cancer	0.000284	0.000466	CcSEcCtD
Mirtazapine—Hypersensitivity—Etoposide—testicular cancer	0.000283	0.000465	CcSEcCtD
Mirtazapine—Tinnitus—Epirubicin—testicular cancer	0.000283	0.000465	CcSEcCtD
Mirtazapine—Malnutrition—Methotrexate—testicular cancer	0.000282	0.000463	CcSEcCtD
Mirtazapine—Cardiac disorder—Epirubicin—testicular cancer	0.000282	0.000462	CcSEcCtD
Mirtazapine—Rhinitis—Doxorubicin—testicular cancer	0.000282	0.000462	CcSEcCtD
Mirtazapine—Hepatitis—Doxorubicin—testicular cancer	0.000281	0.000461	CcSEcCtD
Mirtazapine—Hypoaesthesia—Doxorubicin—testicular cancer	0.000279	0.000459	CcSEcCtD
Mirtazapine—Pharyngitis—Doxorubicin—testicular cancer	0.000279	0.000458	CcSEcCtD
Mirtazapine—Urinary tract disorder—Doxorubicin—testicular cancer	0.000277	0.000455	CcSEcCtD
Mirtazapine—Oedema peripheral—Doxorubicin—testicular cancer	0.000277	0.000454	CcSEcCtD
Mirtazapine—Dysgeusia—Methotrexate—testicular cancer	0.000277	0.000454	CcSEcCtD
Mirtazapine—Asthenia—Etoposide—testicular cancer	0.000276	0.000453	CcSEcCtD
Mirtazapine—Angiopathy—Epirubicin—testicular cancer	0.000275	0.000452	CcSEcCtD
Mirtazapine—Urethral disorder—Doxorubicin—testicular cancer	0.000275	0.000452	CcSEcCtD
Mirtazapine—Back pain—Methotrexate—testicular cancer	0.000273	0.000448	CcSEcCtD
Mirtazapine—Chills—Epirubicin—testicular cancer	0.000272	0.000447	CcSEcCtD
Mirtazapine—Pruritus—Etoposide—testicular cancer	0.000272	0.000447	CcSEcCtD
Mirtazapine—Arrhythmia—Epirubicin—testicular cancer	0.000271	0.000445	CcSEcCtD
Mirtazapine—Alopecia—Epirubicin—testicular cancer	0.000268	0.00044	CcSEcCtD
Mirtazapine—Vomiting—Cisplatin—testicular cancer	0.000267	0.000438	CcSEcCtD
Mirtazapine—Mental disorder—Epirubicin—testicular cancer	0.000266	0.000437	CcSEcCtD
Mirtazapine—Erythema multiforme—Doxorubicin—testicular cancer	0.000266	0.000436	CcSEcCtD
Mirtazapine—Rash—Cisplatin—testicular cancer	0.000265	0.000435	CcSEcCtD
Mirtazapine—Dermatitis—Cisplatin—testicular cancer	0.000265	0.000434	CcSEcCtD
Mirtazapine—Malnutrition—Epirubicin—testicular cancer	0.000264	0.000434	CcSEcCtD
Mirtazapine—Diarrhoea—Etoposide—testicular cancer	0.000263	0.000432	CcSEcCtD
Mirtazapine—Eye disorder—Doxorubicin—testicular cancer	0.000263	0.000431	CcSEcCtD
Mirtazapine—Ill-defined disorder—Methotrexate—testicular cancer	0.000262	0.00043	CcSEcCtD
Mirtazapine—Tinnitus—Doxorubicin—testicular cancer	0.000262	0.00043	CcSEcCtD
Mirtazapine—Anaemia—Methotrexate—testicular cancer	0.000261	0.000428	CcSEcCtD
Mirtazapine—Cardiac disorder—Doxorubicin—testicular cancer	0.000261	0.000428	CcSEcCtD
Mirtazapine—Flatulence—Epirubicin—testicular cancer	0.00026	0.000427	CcSEcCtD
Mirtazapine—Tension—Epirubicin—testicular cancer	0.000259	0.000426	CcSEcCtD
Mirtazapine—Dysgeusia—Epirubicin—testicular cancer	0.000259	0.000425	CcSEcCtD
Mirtazapine—Nervousness—Epirubicin—testicular cancer	0.000257	0.000421	CcSEcCtD
Mirtazapine—Back pain—Epirubicin—testicular cancer	0.000256	0.00042	CcSEcCtD
Mirtazapine—Angiopathy—Doxorubicin—testicular cancer	0.000255	0.000418	CcSEcCtD
Mirtazapine—Malaise—Methotrexate—testicular cancer	0.000255	0.000418	CcSEcCtD
Mirtazapine—Dizziness—Etoposide—testicular cancer	0.000254	0.000418	CcSEcCtD
Mirtazapine—Vertigo—Methotrexate—testicular cancer	0.000254	0.000416	CcSEcCtD
Mirtazapine—Leukopenia—Methotrexate—testicular cancer	0.000253	0.000415	CcSEcCtD
Mirtazapine—Chills—Doxorubicin—testicular cancer	0.000252	0.000414	CcSEcCtD
Mirtazapine—Arrhythmia—Doxorubicin—testicular cancer	0.000251	0.000412	CcSEcCtD
Mirtazapine—Nausea—Cisplatin—testicular cancer	0.000249	0.000409	CcSEcCtD
Mirtazapine—Alopecia—Doxorubicin—testicular cancer	0.000248	0.000407	CcSEcCtD
Mirtazapine—Cough—Methotrexate—testicular cancer	0.000246	0.000404	CcSEcCtD
Mirtazapine—Mental disorder—Doxorubicin—testicular cancer	0.000246	0.000404	CcSEcCtD
Mirtazapine—Ill-defined disorder—Epirubicin—testicular cancer	0.000245	0.000402	CcSEcCtD
Mirtazapine—Convulsion—Methotrexate—testicular cancer	0.000245	0.000402	CcSEcCtD
Mirtazapine—Vomiting—Etoposide—testicular cancer	0.000245	0.000402	CcSEcCtD
Mirtazapine—Malnutrition—Doxorubicin—testicular cancer	0.000245	0.000401	CcSEcCtD
Mirtazapine—Anaemia—Epirubicin—testicular cancer	0.000244	0.000401	CcSEcCtD
Mirtazapine—Agitation—Epirubicin—testicular cancer	0.000243	0.000399	CcSEcCtD
Mirtazapine—Rash—Etoposide—testicular cancer	0.000243	0.000398	CcSEcCtD
Mirtazapine—Dermatitis—Etoposide—testicular cancer	0.000242	0.000398	CcSEcCtD
Mirtazapine—Headache—Etoposide—testicular cancer	0.000241	0.000396	CcSEcCtD
Mirtazapine—Flatulence—Doxorubicin—testicular cancer	0.000241	0.000395	CcSEcCtD
Mirtazapine—Chest pain—Methotrexate—testicular cancer	0.00024	0.000395	CcSEcCtD
Mirtazapine—Myalgia—Methotrexate—testicular cancer	0.00024	0.000395	CcSEcCtD
Mirtazapine—Arthralgia—Methotrexate—testicular cancer	0.00024	0.000395	CcSEcCtD
Mirtazapine—Tension—Doxorubicin—testicular cancer	0.00024	0.000394	CcSEcCtD
Mirtazapine—Dysgeusia—Doxorubicin—testicular cancer	0.000239	0.000393	CcSEcCtD
Mirtazapine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—testicular cancer	0.000239	0.000392	CcSEcCtD
Mirtazapine—Malaise—Epirubicin—testicular cancer	0.000238	0.000391	CcSEcCtD
Mirtazapine—Discomfort—Methotrexate—testicular cancer	0.000238	0.00039	CcSEcCtD
Mirtazapine—Nervousness—Doxorubicin—testicular cancer	0.000237	0.00039	CcSEcCtD
Mirtazapine—Vertigo—Epirubicin—testicular cancer	0.000237	0.00039	CcSEcCtD
Mirtazapine—Syncope—Epirubicin—testicular cancer	0.000237	0.000389	CcSEcCtD
Mirtazapine—Leukopenia—Epirubicin—testicular cancer	0.000237	0.000388	CcSEcCtD
Mirtazapine—Back pain—Doxorubicin—testicular cancer	0.000237	0.000388	CcSEcCtD
Mirtazapine—SLC6A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A6—testicular cancer	0.000236	0.0388	CbGpPWpGaD
Mirtazapine—Palpitations—Epirubicin—testicular cancer	0.000234	0.000383	CcSEcCtD
Mirtazapine—Confusional state—Methotrexate—testicular cancer	0.000232	0.000381	CcSEcCtD
Mirtazapine—Loss of consciousness—Epirubicin—testicular cancer	0.000232	0.000381	CcSEcCtD
Mirtazapine—Cough—Epirubicin—testicular cancer	0.000231	0.000379	CcSEcCtD
Mirtazapine—Convulsion—Epirubicin—testicular cancer	0.000229	0.000376	CcSEcCtD
Mirtazapine—Infection—Methotrexate—testicular cancer	0.000229	0.000376	CcSEcCtD
Mirtazapine—Nausea—Etoposide—testicular cancer	0.000229	0.000375	CcSEcCtD
Mirtazapine—Hypertension—Epirubicin—testicular cancer	0.000228	0.000374	CcSEcCtD
Mirtazapine—Ill-defined disorder—Doxorubicin—testicular cancer	0.000227	0.000372	CcSEcCtD
Mirtazapine—Nervous system disorder—Methotrexate—testicular cancer	0.000226	0.000371	CcSEcCtD
Mirtazapine—Anaemia—Doxorubicin—testicular cancer	0.000226	0.000371	CcSEcCtD
Mirtazapine—Thrombocytopenia—Methotrexate—testicular cancer	0.000226	0.00037	CcSEcCtD
Mirtazapine—Myalgia—Epirubicin—testicular cancer	0.000225	0.000369	CcSEcCtD
Mirtazapine—Arthralgia—Epirubicin—testicular cancer	0.000225	0.000369	CcSEcCtD
Mirtazapine—Chest pain—Epirubicin—testicular cancer	0.000225	0.000369	CcSEcCtD
Mirtazapine—Agitation—Doxorubicin—testicular cancer	0.000225	0.000369	CcSEcCtD
Mirtazapine—Anxiety—Epirubicin—testicular cancer	0.000224	0.000368	CcSEcCtD
Mirtazapine—Skin disorder—Methotrexate—testicular cancer	0.000224	0.000367	CcSEcCtD
Mirtazapine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—testicular cancer	0.000223	0.000367	CcSEcCtD
Mirtazapine—Hyperhidrosis—Methotrexate—testicular cancer	0.000223	0.000366	CcSEcCtD
Mirtazapine—Discomfort—Epirubicin—testicular cancer	0.000222	0.000365	CcSEcCtD
Mirtazapine—Malaise—Doxorubicin—testicular cancer	0.000221	0.000362	CcSEcCtD
Mirtazapine—Dry mouth—Epirubicin—testicular cancer	0.00022	0.000361	CcSEcCtD
Mirtazapine—Vertigo—Doxorubicin—testicular cancer	0.00022	0.000361	CcSEcCtD
Mirtazapine—Anorexia—Methotrexate—testicular cancer	0.00022	0.000361	CcSEcCtD
Mirtazapine—Syncope—Doxorubicin—testicular cancer	0.000219	0.00036	CcSEcCtD
Mirtazapine—Leukopenia—Doxorubicin—testicular cancer	0.000219	0.000359	CcSEcCtD
Mirtazapine—Confusional state—Epirubicin—testicular cancer	0.000217	0.000357	CcSEcCtD
Mirtazapine—Palpitations—Doxorubicin—testicular cancer	0.000216	0.000355	CcSEcCtD
Mirtazapine—Oedema—Epirubicin—testicular cancer	0.000216	0.000354	CcSEcCtD
Mirtazapine—Hypotension—Methotrexate—testicular cancer	0.000215	0.000353	CcSEcCtD
Mirtazapine—Loss of consciousness—Doxorubicin—testicular cancer	0.000215	0.000353	CcSEcCtD
Mirtazapine—Infection—Epirubicin—testicular cancer	0.000214	0.000352	CcSEcCtD
Mirtazapine—Cough—Doxorubicin—testicular cancer	0.000213	0.00035	CcSEcCtD
Mirtazapine—Shock—Epirubicin—testicular cancer	0.000212	0.000348	CcSEcCtD
Mirtazapine—Convulsion—Doxorubicin—testicular cancer	0.000212	0.000348	CcSEcCtD
Mirtazapine—Nervous system disorder—Epirubicin—testicular cancer	0.000212	0.000347	CcSEcCtD
Mirtazapine—Thrombocytopenia—Epirubicin—testicular cancer	0.000211	0.000347	CcSEcCtD
Mirtazapine—Hypertension—Doxorubicin—testicular cancer	0.000211	0.000347	CcSEcCtD
Mirtazapine—Tachycardia—Epirubicin—testicular cancer	0.00021	0.000345	CcSEcCtD
Mirtazapine—Musculoskeletal discomfort—Methotrexate—testicular cancer	0.00021	0.000345	CcSEcCtD
Mirtazapine—Skin disorder—Epirubicin—testicular cancer	0.000209	0.000344	CcSEcCtD
Mirtazapine—SLC6A3—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A6—testicular cancer	0.000209	0.0344	CbGpPWpGaD
Mirtazapine—Hyperhidrosis—Epirubicin—testicular cancer	0.000209	0.000342	CcSEcCtD
Mirtazapine—Insomnia—Methotrexate—testicular cancer	0.000208	0.000342	CcSEcCtD
Mirtazapine—Arthralgia—Doxorubicin—testicular cancer	0.000208	0.000342	CcSEcCtD
Mirtazapine—Chest pain—Doxorubicin—testicular cancer	0.000208	0.000342	CcSEcCtD
Mirtazapine—Myalgia—Doxorubicin—testicular cancer	0.000208	0.000342	CcSEcCtD
Mirtazapine—Anxiety—Doxorubicin—testicular cancer	0.000207	0.000341	CcSEcCtD
Mirtazapine—Paraesthesia—Methotrexate—testicular cancer	0.000207	0.00034	CcSEcCtD
Mirtazapine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—testicular cancer	0.000207	0.000339	CcSEcCtD
Mirtazapine—Discomfort—Doxorubicin—testicular cancer	0.000206	0.000338	CcSEcCtD
Mirtazapine—Anorexia—Epirubicin—testicular cancer	0.000206	0.000337	CcSEcCtD
Mirtazapine—Dyspnoea—Methotrexate—testicular cancer	0.000205	0.000337	CcSEcCtD
Mirtazapine—Somnolence—Methotrexate—testicular cancer	0.000205	0.000336	CcSEcCtD
Mirtazapine—Dry mouth—Doxorubicin—testicular cancer	0.000204	0.000334	CcSEcCtD
Mirtazapine—Dyspepsia—Methotrexate—testicular cancer	0.000203	0.000333	CcSEcCtD
Mirtazapine—Hypotension—Epirubicin—testicular cancer	0.000202	0.000331	CcSEcCtD
Mirtazapine—Confusional state—Doxorubicin—testicular cancer	0.000201	0.00033	CcSEcCtD
Mirtazapine—Decreased appetite—Methotrexate—testicular cancer	0.0002	0.000329	CcSEcCtD
Mirtazapine—Oedema—Doxorubicin—testicular cancer	0.0002	0.000328	CcSEcCtD
Mirtazapine—Gastrointestinal disorder—Methotrexate—testicular cancer	0.000199	0.000327	CcSEcCtD
Mirtazapine—Fatigue—Methotrexate—testicular cancer	0.000199	0.000326	CcSEcCtD
Mirtazapine—Infection—Doxorubicin—testicular cancer	0.000198	0.000325	CcSEcCtD
Mirtazapine—SLC6A4—NRF2 pathway—SLC2A6—testicular cancer	0.000198	0.0325	CbGpPWpGaD
Mirtazapine—Pain—Methotrexate—testicular cancer	0.000197	0.000323	CcSEcCtD
Mirtazapine—Musculoskeletal discomfort—Epirubicin—testicular cancer	0.000196	0.000323	CcSEcCtD
Mirtazapine—Shock—Doxorubicin—testicular cancer	0.000196	0.000322	CcSEcCtD
Mirtazapine—Nervous system disorder—Doxorubicin—testicular cancer	0.000196	0.000321	CcSEcCtD
Mirtazapine—Thrombocytopenia—Doxorubicin—testicular cancer	0.000195	0.000321	CcSEcCtD
Mirtazapine—Insomnia—Epirubicin—testicular cancer	0.000195	0.00032	CcSEcCtD
Mirtazapine—Tachycardia—Doxorubicin—testicular cancer	0.000195	0.00032	CcSEcCtD
Mirtazapine—Skin disorder—Doxorubicin—testicular cancer	0.000194	0.000318	CcSEcCtD
Mirtazapine—Paraesthesia—Epirubicin—testicular cancer	0.000194	0.000318	CcSEcCtD
Mirtazapine—Hyperhidrosis—Doxorubicin—testicular cancer	0.000193	0.000317	CcSEcCtD
Mirtazapine—Dyspnoea—Epirubicin—testicular cancer	0.000192	0.000316	CcSEcCtD
Mirtazapine—Somnolence—Epirubicin—testicular cancer	0.000192	0.000315	CcSEcCtD
Mirtazapine—Anorexia—Doxorubicin—testicular cancer	0.00019	0.000312	CcSEcCtD
Mirtazapine—Feeling abnormal—Methotrexate—testicular cancer	0.00019	0.000312	CcSEcCtD
Mirtazapine—Dyspepsia—Epirubicin—testicular cancer	0.00019	0.000312	CcSEcCtD
Mirtazapine—Gastrointestinal pain—Methotrexate—testicular cancer	0.000188	0.000309	CcSEcCtD
Mirtazapine—Decreased appetite—Epirubicin—testicular cancer	0.000187	0.000308	CcSEcCtD
Mirtazapine—Hypotension—Doxorubicin—testicular cancer	0.000186	0.000306	CcSEcCtD
Mirtazapine—Gastrointestinal disorder—Epirubicin—testicular cancer	0.000186	0.000306	CcSEcCtD
Mirtazapine—Fatigue—Epirubicin—testicular cancer	0.000186	0.000305	CcSEcCtD
Mirtazapine—Pain—Epirubicin—testicular cancer	0.000184	0.000303	CcSEcCtD
Mirtazapine—Constipation—Epirubicin—testicular cancer	0.000184	0.000303	CcSEcCtD
Mirtazapine—Urticaria—Methotrexate—testicular cancer	0.000183	0.000301	CcSEcCtD
Mirtazapine—Abdominal pain—Methotrexate—testicular cancer	0.000182	0.000299	CcSEcCtD
Mirtazapine—Body temperature increased—Methotrexate—testicular cancer	0.000182	0.000299	CcSEcCtD
Mirtazapine—Musculoskeletal discomfort—Doxorubicin—testicular cancer	0.000182	0.000298	CcSEcCtD
Mirtazapine—Insomnia—Doxorubicin—testicular cancer	0.00018	0.000296	CcSEcCtD
Mirtazapine—Paraesthesia—Doxorubicin—testicular cancer	0.000179	0.000294	CcSEcCtD
Mirtazapine—Dyspnoea—Doxorubicin—testicular cancer	0.000178	0.000292	CcSEcCtD
Mirtazapine—Feeling abnormal—Epirubicin—testicular cancer	0.000178	0.000292	CcSEcCtD
Mirtazapine—Somnolence—Doxorubicin—testicular cancer	0.000177	0.000291	CcSEcCtD
Mirtazapine—Gastrointestinal pain—Epirubicin—testicular cancer	0.000176	0.000289	CcSEcCtD
Mirtazapine—Dyspepsia—Doxorubicin—testicular cancer	0.000176	0.000288	CcSEcCtD
Mirtazapine—HTR7—G alpha (s) signalling events—INSL3—testicular cancer	0.000176	0.0289	CbGpPWpGaD
Mirtazapine—Decreased appetite—Doxorubicin—testicular cancer	0.000173	0.000285	CcSEcCtD
Mirtazapine—Gastrointestinal disorder—Doxorubicin—testicular cancer	0.000172	0.000283	CcSEcCtD
Mirtazapine—Fatigue—Doxorubicin—testicular cancer	0.000172	0.000282	CcSEcCtD
Mirtazapine—Urticaria—Epirubicin—testicular cancer	0.000171	0.000281	CcSEcCtD
Mirtazapine—Pain—Doxorubicin—testicular cancer	0.000171	0.00028	CcSEcCtD
Mirtazapine—Constipation—Doxorubicin—testicular cancer	0.000171	0.00028	CcSEcCtD
Mirtazapine—Abdominal pain—Epirubicin—testicular cancer	0.00017	0.00028	CcSEcCtD
Mirtazapine—Body temperature increased—Epirubicin—testicular cancer	0.00017	0.00028	CcSEcCtD
Mirtazapine—SLC6A2—NRF2 pathway—SLC2A6—testicular cancer	0.00017	0.028	CbGpPWpGaD
Mirtazapine—Hypersensitivity—Methotrexate—testicular cancer	0.00017	0.000279	CcSEcCtD
Mirtazapine—Asthenia—Methotrexate—testicular cancer	0.000165	0.000271	CcSEcCtD
Mirtazapine—Feeling abnormal—Doxorubicin—testicular cancer	0.000164	0.00027	CcSEcCtD
Mirtazapine—Gastrointestinal pain—Doxorubicin—testicular cancer	0.000163	0.000268	CcSEcCtD
Mirtazapine—Pruritus—Methotrexate—testicular cancer	0.000163	0.000268	CcSEcCtD
Mirtazapine—HRH3—Class A/1 (Rhodopsin-like receptors)—INSL3—testicular cancer	0.000162	0.0266	CbGpPWpGaD
Mirtazapine—Hypersensitivity—Epirubicin—testicular cancer	0.000159	0.000261	CcSEcCtD
Mirtazapine—Urticaria—Doxorubicin—testicular cancer	0.000159	0.00026	CcSEcCtD
Mirtazapine—Body temperature increased—Doxorubicin—testicular cancer	0.000158	0.000259	CcSEcCtD
Mirtazapine—Abdominal pain—Doxorubicin—testicular cancer	0.000158	0.000259	CcSEcCtD
Mirtazapine—Diarrhoea—Methotrexate—testicular cancer	0.000158	0.000259	CcSEcCtD
Mirtazapine—Asthenia—Epirubicin—testicular cancer	0.000155	0.000254	CcSEcCtD
Mirtazapine—Pruritus—Epirubicin—testicular cancer	0.000153	0.00025	CcSEcCtD
Mirtazapine—Dizziness—Methotrexate—testicular cancer	0.000152	0.00025	CcSEcCtD
Mirtazapine—SLC6A3—NRF2 pathway—SLC2A6—testicular cancer	0.000151	0.0248	CbGpPWpGaD
Mirtazapine—Diarrhoea—Epirubicin—testicular cancer	0.000148	0.000242	CcSEcCtD
Mirtazapine—Hypersensitivity—Doxorubicin—testicular cancer	0.000147	0.000241	CcSEcCtD
Mirtazapine—Vomiting—Methotrexate—testicular cancer	0.000147	0.000241	CcSEcCtD
Mirtazapine—Rash—Methotrexate—testicular cancer	0.000145	0.000239	CcSEcCtD
Mirtazapine—Dermatitis—Methotrexate—testicular cancer	0.000145	0.000238	CcSEcCtD
Mirtazapine—Headache—Methotrexate—testicular cancer	0.000144	0.000237	CcSEcCtD
Mirtazapine—Asthenia—Doxorubicin—testicular cancer	0.000143	0.000235	CcSEcCtD
Mirtazapine—Dizziness—Epirubicin—testicular cancer	0.000143	0.000234	CcSEcCtD
Mirtazapine—Pruritus—Doxorubicin—testicular cancer	0.000141	0.000232	CcSEcCtD
Mirtazapine—Vomiting—Epirubicin—testicular cancer	0.000137	0.000225	CcSEcCtD
Mirtazapine—Nausea—Methotrexate—testicular cancer	0.000137	0.000225	CcSEcCtD
Mirtazapine—Diarrhoea—Doxorubicin—testicular cancer	0.000137	0.000224	CcSEcCtD
Mirtazapine—ADRB1—G alpha (s) signalling events—INSL3—testicular cancer	0.000136	0.0224	CbGpPWpGaD
Mirtazapine—Rash—Epirubicin—testicular cancer	0.000136	0.000223	CcSEcCtD
Mirtazapine—Dermatitis—Epirubicin—testicular cancer	0.000136	0.000223	CcSEcCtD
Mirtazapine—Headache—Epirubicin—testicular cancer	0.000135	0.000222	CcSEcCtD
Mirtazapine—ADRB2—G alpha (s) signalling events—INSL3—testicular cancer	0.000133	0.0219	CbGpPWpGaD
Mirtazapine—Dizziness—Doxorubicin—testicular cancer	0.000132	0.000217	CcSEcCtD
Mirtazapine—Nausea—Epirubicin—testicular cancer	0.000128	0.00021	CcSEcCtD
Mirtazapine—Vomiting—Doxorubicin—testicular cancer	0.000127	0.000208	CcSEcCtD
Mirtazapine—OPRK1—Peptide ligand-binding receptors—INSL3—testicular cancer	0.000127	0.0209	CbGpPWpGaD
Mirtazapine—Rash—Doxorubicin—testicular cancer	0.000126	0.000207	CcSEcCtD
Mirtazapine—Dermatitis—Doxorubicin—testicular cancer	0.000126	0.000206	CcSEcCtD
Mirtazapine—Headache—Doxorubicin—testicular cancer	0.000125	0.000205	CcSEcCtD
Mirtazapine—HRH3—GPCR ligand binding—INSL3—testicular cancer	0.000123	0.0203	CbGpPWpGaD
Mirtazapine—Nausea—Doxorubicin—testicular cancer	0.000119	0.000195	CcSEcCtD
Mirtazapine—SLC6A2—SLC-mediated transmembrane transport—SLC2A6—testicular cancer	0.000107	0.0176	CbGpPWpGaD
Mirtazapine—HTR3A—Transmembrane transport of small molecules—SLC2A6—testicular cancer	0.000101	0.0167	CbGpPWpGaD
Mirtazapine—SLC6A3—SLC-mediated transmembrane transport—SLC2A6—testicular cancer	9.49e-05	0.0156	CbGpPWpGaD
Mirtazapine—OPRK1—Class A/1 (Rhodopsin-like receptors)—INSL3—testicular cancer	8.5e-05	0.014	CbGpPWpGaD
Mirtazapine—HTR7—Class A/1 (Rhodopsin-like receptors)—INSL3—testicular cancer	8.37e-05	0.0138	CbGpPWpGaD
Mirtazapine—DRD4—Class A/1 (Rhodopsin-like receptors)—INSL3—testicular cancer	8.01e-05	0.0132	CbGpPWpGaD
Mirtazapine—HTR2B—Class A/1 (Rhodopsin-like receptors)—INSL3—testicular cancer	7.65e-05	0.0126	CbGpPWpGaD
Mirtazapine—CYP2C8—Arachidonic acid metabolism—HPGDS—testicular cancer	7.35e-05	0.0121	CbGpPWpGaD
Mirtazapine—DRD3—Class A/1 (Rhodopsin-like receptors)—INSL3—testicular cancer	7.12e-05	0.0117	CbGpPWpGaD
Mirtazapine—HRH3—GPCR downstream signaling—INSL3—testicular cancer	6.97e-05	0.0115	CbGpPWpGaD
Mirtazapine—ADRB1—Class A/1 (Rhodopsin-like receptors)—INSL3—testicular cancer	6.49e-05	0.0107	CbGpPWpGaD
Mirtazapine—OPRK1—GPCR ligand binding—INSL3—testicular cancer	6.48e-05	0.0107	CbGpPWpGaD
Mirtazapine—HTR7—GPCR ligand binding—INSL3—testicular cancer	6.37e-05	0.0105	CbGpPWpGaD
Mirtazapine—ADRB2—Class A/1 (Rhodopsin-like receptors)—INSL3—testicular cancer	6.34e-05	0.0104	CbGpPWpGaD
Mirtazapine—HRH3—Signaling by GPCR—INSL3—testicular cancer	6.33e-05	0.0104	CbGpPWpGaD
Mirtazapine—HTR1A—Class A/1 (Rhodopsin-like receptors)—INSL3—testicular cancer	6.2e-05	0.0102	CbGpPWpGaD
Mirtazapine—HTR2C—Class A/1 (Rhodopsin-like receptors)—INSL3—testicular cancer	6.17e-05	0.0102	CbGpPWpGaD
Mirtazapine—DRD4—GPCR ligand binding—INSL3—testicular cancer	6.1e-05	0.01	CbGpPWpGaD
Mirtazapine—ADRA2C—Class A/1 (Rhodopsin-like receptors)—INSL3—testicular cancer	6e-05	0.00987	CbGpPWpGaD
Mirtazapine—CYP2C9—Arachidonic acid metabolism—HPGDS—testicular cancer	5.98e-05	0.00984	CbGpPWpGaD
Mirtazapine—HTR2B—GPCR ligand binding—INSL3—testicular cancer	5.82e-05	0.00958	CbGpPWpGaD
Mirtazapine—ADRA1A—AMPK Signaling—STK11—testicular cancer	5.6e-05	0.00921	CbGpPWpGaD
Mirtazapine—CYP1A2—Aryl Hydrocarbon Receptor—HPGDS—testicular cancer	5.47e-05	0.00899	CbGpPWpGaD
Mirtazapine—SLC6A2—Transmembrane transport of small molecules—SLC2A6—testicular cancer	5.45e-05	0.00896	CbGpPWpGaD
Mirtazapine—DRD2—Class A/1 (Rhodopsin-like receptors)—INSL3—testicular cancer	5.45e-05	0.00896	CbGpPWpGaD
Mirtazapine—DRD3—GPCR ligand binding—INSL3—testicular cancer	5.42e-05	0.00892	CbGpPWpGaD
Mirtazapine—HTR2A—Class A/1 (Rhodopsin-like receptors)—INSL3—testicular cancer	5.36e-05	0.00881	CbGpPWpGaD
Mirtazapine—HRH1—Class A/1 (Rhodopsin-like receptors)—INSL3—testicular cancer	5.35e-05	0.0088	CbGpPWpGaD
Mirtazapine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—INSL3—testicular cancer	5.25e-05	0.00863	CbGpPWpGaD
Mirtazapine—CYP1A2—Arachidonic acid metabolism—HPGDS—testicular cancer	5.11e-05	0.00841	CbGpPWpGaD
Mirtazapine—ADRB1—GPCR ligand binding—INSL3—testicular cancer	4.94e-05	0.00812	CbGpPWpGaD
Mirtazapine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—INSL3—testicular cancer	4.88e-05	0.00802	CbGpPWpGaD
Mirtazapine—ADRB2—GPCR ligand binding—INSL3—testicular cancer	4.83e-05	0.00795	CbGpPWpGaD
Mirtazapine—SLC6A3—Transmembrane transport of small molecules—SLC2A6—testicular cancer	4.82e-05	0.00794	CbGpPWpGaD
Mirtazapine—HTR1A—GPCR ligand binding—INSL3—testicular cancer	4.72e-05	0.00777	CbGpPWpGaD
Mirtazapine—HTR2C—GPCR ligand binding—INSL3—testicular cancer	4.7e-05	0.00773	CbGpPWpGaD
Mirtazapine—ADRA2C—Integration of energy metabolism—STK11—testicular cancer	4.61e-05	0.00759	CbGpPWpGaD
Mirtazapine—ADRA2C—GPCR ligand binding—INSL3—testicular cancer	4.57e-05	0.00752	CbGpPWpGaD
Mirtazapine—DRD2—GPCR ligand binding—INSL3—testicular cancer	4.15e-05	0.00682	CbGpPWpGaD
Mirtazapine—HTR2A—GPCR ligand binding—INSL3—testicular cancer	4.08e-05	0.00671	CbGpPWpGaD
Mirtazapine—HRH1—GPCR ligand binding—INSL3—testicular cancer	4.07e-05	0.0067	CbGpPWpGaD
Mirtazapine—ADRA1A—GPCR ligand binding—INSL3—testicular cancer	4e-05	0.00657	CbGpPWpGaD
Mirtazapine—ADRA2A—Integration of energy metabolism—STK11—testicular cancer	3.75e-05	0.00616	CbGpPWpGaD
Mirtazapine—HRH3—Signaling Pathways—INSL3—testicular cancer	3.74e-05	0.00615	CbGpPWpGaD
Mirtazapine—ADRA2A—GPCR ligand binding—INSL3—testicular cancer	3.71e-05	0.00611	CbGpPWpGaD
Mirtazapine—OPRK1—GPCR downstream signaling—INSL3—testicular cancer	3.66e-05	0.00602	CbGpPWpGaD
Mirtazapine—HTR7—GPCR downstream signaling—INSL3—testicular cancer	3.6e-05	0.00593	CbGpPWpGaD
Mirtazapine—DRD4—GPCR downstream signaling—INSL3—testicular cancer	3.45e-05	0.00567	CbGpPWpGaD
Mirtazapine—OPRK1—Signaling by GPCR—INSL3—testicular cancer	3.32e-05	0.00547	CbGpPWpGaD
Mirtazapine—HTR2B—GPCR downstream signaling—INSL3—testicular cancer	3.29e-05	0.00541	CbGpPWpGaD
Mirtazapine—HTR7—Signaling by GPCR—INSL3—testicular cancer	3.27e-05	0.00538	CbGpPWpGaD
Mirtazapine—CYP1A2—Phase II conjugation—HPGDS—testicular cancer	3.25e-05	0.00535	CbGpPWpGaD
Mirtazapine—DRD4—Signaling by GPCR—INSL3—testicular cancer	3.13e-05	0.00515	CbGpPWpGaD
Mirtazapine—DRD3—GPCR downstream signaling—INSL3—testicular cancer	3.06e-05	0.00504	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling by GPCR—INSL3—testicular cancer	2.99e-05	0.00492	CbGpPWpGaD
Mirtazapine—ADRB1—GPCR downstream signaling—INSL3—testicular cancer	2.79e-05	0.00459	CbGpPWpGaD
Mirtazapine—DRD3—Signaling by GPCR—INSL3—testicular cancer	2.78e-05	0.00458	CbGpPWpGaD
Mirtazapine—CYP2C8—Biological oxidations—HPGDS—testicular cancer	2.74e-05	0.0045	CbGpPWpGaD
Mirtazapine—ADRB2—GPCR downstream signaling—INSL3—testicular cancer	2.73e-05	0.00449	CbGpPWpGaD
Mirtazapine—HTR1A—GPCR downstream signaling—INSL3—testicular cancer	2.67e-05	0.00439	CbGpPWpGaD
Mirtazapine—HTR2C—GPCR downstream signaling—INSL3—testicular cancer	2.66e-05	0.00437	CbGpPWpGaD
Mirtazapine—ADRA2C—GPCR downstream signaling—INSL3—testicular cancer	2.58e-05	0.00425	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling by GPCR—INSL3—testicular cancer	2.53e-05	0.00417	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling by GPCR—INSL3—testicular cancer	2.48e-05	0.00408	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling by GPCR—INSL3—testicular cancer	2.42e-05	0.00399	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling by GPCR—INSL3—testicular cancer	2.41e-05	0.00397	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling by GPCR—INSL3—testicular cancer	2.35e-05	0.00386	CbGpPWpGaD
Mirtazapine—DRD2—GPCR downstream signaling—INSL3—testicular cancer	2.34e-05	0.00386	CbGpPWpGaD
Mirtazapine—HTR2A—GPCR downstream signaling—INSL3—testicular cancer	2.31e-05	0.00379	CbGpPWpGaD
Mirtazapine—HRH1—GPCR downstream signaling—INSL3—testicular cancer	2.3e-05	0.00379	CbGpPWpGaD
Mirtazapine—ADRA1A—GPCR downstream signaling—INSL3—testicular cancer	2.26e-05	0.00371	CbGpPWpGaD
Mirtazapine—CYP2D6—Biological oxidations—HPGDS—testicular cancer	2.25e-05	0.0037	CbGpPWpGaD
Mirtazapine—CYP2C9—Biological oxidations—HPGDS—testicular cancer	2.23e-05	0.00366	CbGpPWpGaD
Mirtazapine—DRD2—Signaling by GPCR—INSL3—testicular cancer	2.13e-05	0.0035	CbGpPWpGaD
Mirtazapine—ADRA2A—GPCR downstream signaling—INSL3—testicular cancer	2.1e-05	0.00345	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling by GPCR—INSL3—testicular cancer	2.09e-05	0.00344	CbGpPWpGaD
Mirtazapine—HRH1—Signaling by GPCR—INSL3—testicular cancer	2.09e-05	0.00344	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling by GPCR—INSL3—testicular cancer	2.05e-05	0.00337	CbGpPWpGaD
Mirtazapine—OPRK1—Signaling Pathways—INSL3—testicular cancer	1.96e-05	0.00323	CbGpPWpGaD
Mirtazapine—HTR7—Signaling Pathways—INSL3—testicular cancer	1.93e-05	0.00318	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling by GPCR—INSL3—testicular cancer	1.91e-05	0.00313	CbGpPWpGaD
Mirtazapine—CYP1A2—Biological oxidations—HPGDS—testicular cancer	1.9e-05	0.00313	CbGpPWpGaD
Mirtazapine—DRD4—Signaling Pathways—INSL3—testicular cancer	1.85e-05	0.00304	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—INSL3—testicular cancer	1.77e-05	0.0029	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—INSL3—testicular cancer	1.64e-05	0.0027	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—INSL3—testicular cancer	1.5e-05	0.00246	CbGpPWpGaD
Mirtazapine—CYP3A4—Biological oxidations—HPGDS—testicular cancer	1.47e-05	0.00242	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—INSL3—testicular cancer	1.46e-05	0.00241	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—INSL3—testicular cancer	1.43e-05	0.00236	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—INSL3—testicular cancer	1.42e-05	0.00234	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—INSL3—testicular cancer	1.39e-05	0.00228	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—INSL3—testicular cancer	1.26e-05	0.00207	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—INSL3—testicular cancer	1.24e-05	0.00203	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—INSL3—testicular cancer	1.23e-05	0.00203	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—INSL3—testicular cancer	1.21e-05	0.00199	CbGpPWpGaD
Mirtazapine—HRH3—Signaling Pathways—H2AFZ—testicular cancer	1.2e-05	0.00197	CbGpPWpGaD
Mirtazapine—HRH3—Signaling Pathways—STK11—testicular cancer	1.19e-05	0.00196	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—INSL3—testicular cancer	1.13e-05	0.00185	CbGpPWpGaD
Mirtazapine—HRH3—Signaling Pathways—KITLG—testicular cancer	1.1e-05	0.00181	CbGpPWpGaD
Mirtazapine—CYP2C8—Metabolism of lipids and lipoproteins—HPGDS—testicular cancer	1.05e-05	0.00173	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism of lipids and lipoproteins—HPGDS—testicular cancer	8.55e-06	0.00141	CbGpPWpGaD
Mirtazapine—HRH3—Signaling Pathways—FGFR3—testicular cancer	8.18e-06	0.00135	CbGpPWpGaD
Mirtazapine—HRH3—Signaling Pathways—KIT—testicular cancer	7.51e-06	0.00124	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism of lipids and lipoproteins—HPGDS—testicular cancer	7.31e-06	0.0012	CbGpPWpGaD
Mirtazapine—ADRA2C—Metabolism—HPGDS—testicular cancer	7.26e-06	0.00119	CbGpPWpGaD
Mirtazapine—OPRK1—Signaling Pathways—H2AFZ—testicular cancer	6.28e-06	0.00103	CbGpPWpGaD
Mirtazapine—OPRK1—Signaling Pathways—STK11—testicular cancer	6.25e-06	0.00103	CbGpPWpGaD
Mirtazapine—HTR7—Signaling Pathways—H2AFZ—testicular cancer	6.19e-06	0.00102	CbGpPWpGaD
Mirtazapine—HTR7—Signaling Pathways—STK11—testicular cancer	6.15e-06	0.00101	CbGpPWpGaD
Mirtazapine—DRD4—Signaling Pathways—H2AFZ—testicular cancer	5.92e-06	0.000974	CbGpPWpGaD
Mirtazapine—ADRA2A—Metabolism—HPGDS—testicular cancer	5.9e-06	0.00097	CbGpPWpGaD
Mirtazapine—DRD4—Signaling Pathways—STK11—testicular cancer	5.89e-06	0.000968	CbGpPWpGaD
Mirtazapine—OPRK1—Signaling Pathways—KITLG—testicular cancer	5.78e-06	0.000951	CbGpPWpGaD
Mirtazapine—HTR7—Signaling Pathways—KITLG—testicular cancer	5.69e-06	0.000936	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—H2AFZ—testicular cancer	5.65e-06	0.00093	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—STK11—testicular cancer	5.62e-06	0.000924	CbGpPWpGaD
Mirtazapine—DRD4—Signaling Pathways—KITLG—testicular cancer	5.45e-06	0.000896	CbGpPWpGaD
Mirtazapine—ADRA2C—Metabolism—STK11—testicular cancer	5.27e-06	0.000868	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—H2AFZ—testicular cancer	5.26e-06	0.000865	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—STK11—testicular cancer	5.23e-06	0.00086	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—KITLG—testicular cancer	5.2e-06	0.000855	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—KITLG—testicular cancer	4.84e-06	0.000796	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—H2AFZ—testicular cancer	4.79e-06	0.000788	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—STK11—testicular cancer	4.76e-06	0.000784	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—H2AFZ—testicular cancer	4.69e-06	0.000771	CbGpPWpGaD
Mirtazapine—CYP2C8—Metabolism—HPGDS—testicular cancer	4.68e-06	0.00077	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—STK11—testicular cancer	4.66e-06	0.000767	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—H2AFZ—testicular cancer	4.58e-06	0.000754	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—H2AFZ—testicular cancer	4.56e-06	0.00075	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—STK11—testicular cancer	4.56e-06	0.00075	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—STK11—testicular cancer	4.53e-06	0.000746	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—H2AFZ—testicular cancer	4.44e-06	0.00073	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—STK11—testicular cancer	4.41e-06	0.000725	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—KITLG—testicular cancer	4.41e-06	0.000725	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—KITLG—testicular cancer	4.31e-06	0.000709	CbGpPWpGaD
Mirtazapine—OPRK1—Signaling Pathways—FGFR3—testicular cancer	4.3e-06	0.000707	CbGpPWpGaD
Mirtazapine—ADRA2A—Metabolism—STK11—testicular cancer	4.28e-06	0.000705	CbGpPWpGaD
Mirtazapine—HTR7—Signaling Pathways—FGFR3—testicular cancer	4.23e-06	0.000696	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—KITLG—testicular cancer	4.22e-06	0.000694	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—KITLG—testicular cancer	4.2e-06	0.00069	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—KITLG—testicular cancer	4.08e-06	0.000671	CbGpPWpGaD
Mirtazapine—DRD4—Signaling Pathways—FGFR3—testicular cancer	4.05e-06	0.000666	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—H2AFZ—testicular cancer	4.02e-06	0.000662	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—STK11—testicular cancer	4e-06	0.000658	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—H2AFZ—testicular cancer	3.96e-06	0.000651	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—H2AFZ—testicular cancer	3.95e-06	0.00065	CbGpPWpGaD
Mirtazapine—OPRK1—Signaling Pathways—KIT—testicular cancer	3.94e-06	0.000649	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—STK11—testicular cancer	3.94e-06	0.000648	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—STK11—testicular cancer	3.93e-06	0.000646	CbGpPWpGaD
Mirtazapine—HTR7—Signaling Pathways—KIT—testicular cancer	3.88e-06	0.000639	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—H2AFZ—testicular cancer	3.88e-06	0.000638	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—FGFR3—testicular cancer	3.86e-06	0.000636	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—STK11—testicular cancer	3.86e-06	0.000634	CbGpPWpGaD
Mirtazapine—CYP2D6—Metabolism—HPGDS—testicular cancer	3.84e-06	0.000632	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism—HPGDS—testicular cancer	3.81e-06	0.000627	CbGpPWpGaD
Mirtazapine—DRD4—Signaling Pathways—KIT—testicular cancer	3.72e-06	0.000611	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—KITLG—testicular cancer	3.7e-06	0.000609	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—KITLG—testicular cancer	3.64e-06	0.000599	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—KITLG—testicular cancer	3.64e-06	0.000598	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—H2AFZ—testicular cancer	3.6e-06	0.000593	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—FGFR3—testicular cancer	3.6e-06	0.000592	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—STK11—testicular cancer	3.58e-06	0.000589	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—KITLG—testicular cancer	3.57e-06	0.000587	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—KIT—testicular cancer	3.55e-06	0.000584	CbGpPWpGaD
Mirtazapine—CYP2C8—Metabolism—STK11—testicular cancer	3.4e-06	0.000559	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—KITLG—testicular cancer	3.31e-06	0.000545	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—KIT—testicular cancer	3.3e-06	0.000543	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—FGFR3—testicular cancer	3.28e-06	0.000539	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—HPGDS—testicular cancer	3.25e-06	0.000535	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—FGFR3—testicular cancer	3.21e-06	0.000527	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—FGFR3—testicular cancer	3.13e-06	0.000516	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—FGFR3—testicular cancer	3.12e-06	0.000513	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—FGFR3—testicular cancer	3.03e-06	0.000499	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—KIT—testicular cancer	3.01e-06	0.000495	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—KIT—testicular cancer	2.94e-06	0.000484	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—KIT—testicular cancer	2.88e-06	0.000473	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—KIT—testicular cancer	2.86e-06	0.000471	CbGpPWpGaD
Mirtazapine—CYP2D6—Metabolism—STK11—testicular cancer	2.79e-06	0.000459	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—KIT—testicular cancer	2.78e-06	0.000458	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism—STK11—testicular cancer	2.77e-06	0.000455	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—FGFR3—testicular cancer	2.75e-06	0.000453	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—FGFR3—testicular cancer	2.71e-06	0.000445	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—FGFR3—testicular cancer	2.7e-06	0.000444	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—FGFR3—testicular cancer	2.65e-06	0.000436	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—KIT—testicular cancer	2.53e-06	0.000416	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—HPGDS—testicular cancer	2.51e-06	0.000413	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—KIT—testicular cancer	2.49e-06	0.000409	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—KIT—testicular cancer	2.48e-06	0.000408	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—FGFR3—testicular cancer	2.46e-06	0.000405	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—KIT—testicular cancer	2.43e-06	0.0004	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—STK11—testicular cancer	2.36e-06	0.000389	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—KIT—testicular cancer	2.26e-06	0.000372	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—STK11—testicular cancer	1.83e-06	0.0003	CbGpPWpGaD
